Discover 156 paid clinical trials in Fayetteville, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 156
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
for
Multiple Myeloma (MM)
Location: Springdale AR, Houston TX, Covington LA, Dyer IN,
Sponsor: Shanghai Henlius Biotech
Sex: All
Age: 18+
Code: NCT07477587
Phase 1, Recruiting
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
for
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Location: Springdale AR, Dallas TX, Omaha NE, Decatur IL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07063745
Phase 2, Phase 3, Recruiting
First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors
for
Solid Tumors (Phase 1)
Location: Springdale AR, Houston TX, New Haven CT
Sponsor: Adcendo ApS
Sex: All
Age: 18+
Code: NCT07362888
Phase 1, Recruiting
Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas
Get alerts for new trials in your area by subscribing now
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
for
Leukemia, Lymphocytic, Chronic, B-Cell,
Location: Springdale AR, Kansas City MO, Hattiesburg MS,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05947851
Phase 3, Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Springdale AR, St Louis MO, Fort Worth TX,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06890598
Phase 3, Recruiting
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy
for
NSCLC Stage IV
Location: Springdale AR, Springfield MO, Hot Springs AR,
Sponsor: ImmunityBio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06745908
Phase 3, Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Location: Springdale AR, Springfield MO, Westwood KS, Memphis TN,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06119581
Phase 3, Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab
for
B-Cell ALL, B-Cell Acute Lymphoblastic Leukaemia,
Location: Springdale AR, Little Rock AR
Sponsor: Arkansas Children's Hospital Research Institute
Sex: All
Age: 1 - 23
Code: NCT07422337
Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Randomized Withdrawal Study in Patients With Schizophrenia
for
Schizophrenia
Location: Rogers AR, Richardson TX, Saint Charles MO, St Louis MO,
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT06961968
Phase 3, Recruiting
A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors
for
Solid Tumors
Location: Rogers AR, Houston TX, San Antonio TX, Grand Rapids MI,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT07123103
Phase 1, Recruiting
New
A Study to Evaluate BMS-986511 in Adults With Major Depressive Disorder
for
Major Depressive Disorder
Location: Rogers AR, Little Rock AR, Atlanta GA
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18 - 65
Code: NCT07772531
Phase 2, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Springdale AR, Kansas City MO, Shreveport LA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06692738
Phase 3, Recruiting
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder
Location: Rogers AR, Little Rock AR, Norman OK, Dallas TX,